http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200106061-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bdd40041a585b2fbeb8bad59beb1449
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2019-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48beb703e9aa05e64d56d5d924cb60df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7be88373703d1e78554a298d784caea0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7761d67d131b84c3877a5ad1bcbaefc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e004d05454d356dd0c1e8e7bc35c55ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f31b75ee96daabed50d28ec0567e8458
publicationDate 2020-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20200106061-A
titleOfInvention 2,4,6,7-tetrahydro-pyrazolo[4,3-D]pyrimidin-5-one derivatives and related compounds as C5A receptor modulators for the treatment of vasculitis and inflammatory diseases
abstract The present invention is a derivative of the following formula (I) (Wherein, rings A, X, Y, Z, R A , R 1 , R 2 , R 3 and R 4 are as described in the specification), their preparation, their pharmaceutically acceptable salts, and pharmaceuticals To their use as, pharmaceutical compositions containing at least one compound of formula (I), and in particular to their use as C5a receptor modulators.
priorityDate 2018-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006042102-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014134426-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467226382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466090567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467104143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467226383

Total number of triples: 31.